Type II Diabetes with Major Cardiovascular Risk (GLP116174 “Harmony”)

Diabetes is treatable, but even when glucose levels are under control it greatly increases the risk of heart disease and stroke. That’s because people with diabetes, particularly type 2 diabetes, often have the following conditions that contribute to their risk for developing cardiovascular disease.

  • High blood pressure (hypertension)
  • Abnormal cholesterol and high triglycerides
  • Obesity
  • Lack of physical activity
  • Poorly controlled blood sugars (too high) or out of normal range
  • SmokingIndividuals with insulin resistance or diabetes in combination with one or more of these risk factors are more likely to fall victim to heart disease or stroke. However, by controlling these risk factors, diabetes patients may avoid or delay the development of heart and blood vessel disease. Your health care provider will do periodic testing to assess whether you have developed any of these risk factors associated with cardiovascular disease.

To compare if adding albiglutide to standard of care blood glucose lowering therapies has any impact on major cardiovascular events in patients with Type II Diabetes.


Click here for more information.

Register Today!

Trial Information

Start DateJuly 2015
End Date2019
Trial Duration3-5 years
Number of VisitsEvery 4 Months
Lead CRCJessica Richer

For additional information
on this trial contact: